116 related articles for article (PubMed ID: 1447805)
1. [Flow cytometric analysis, mechanism of action and evaluation of viability by antineoplastic agents].
Kawamoto K
Nihon Rinsho; 1992 Oct; 50(10):2360-7. PubMed ID: 1447805
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric BrdU/DNA assay for anticancer agent sensitivity test].
Katayanagi N; Suzuki T; Tanaka O; Muto T
Nihon Rinsho; 1992 Oct; 50(10):2386-90. PubMed ID: 1280306
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric studies of brain tumors--5: New sensitivity test of antineoplastic agents for brain tumors and its clinical application].
Kawakami K; Kawamoto K; Oka N; Kawamura Y; Matsumura H; Ito T; Ohyama A
No Shinkei Geka; 1986 Apr; 14(5):627-34. PubMed ID: 2425281
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytometric analysis of cell cycle for the action mechanism of antineoplastic agents].
Kawamoto K
Hum Cell; 1995 Sep; 8(3):85-8. PubMed ID: 8652450
[TBL] [Abstract][Full Text] [Related]
5. [Application of simultaneous flow cytometric bromodeoxyuridine (BrdU)/DNA analysis. 2. Basic study to apply as a chemosensitivity test].
Shimabukuro T
Hinyokika Kiyo; 1988 Aug; 34(8):1349-55. PubMed ID: 3195402
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of cell kinetics using BrdU monoclonal antibody on cultured tumor cells after irradiation and treatment with anti-cancer drugs].
Kataoka M; Akagi K; Kobayashi K; Ooyama A; Tanaka Y
Hum Cell; 1990 Mar; 3(1):45-51. PubMed ID: 2083223
[TBL] [Abstract][Full Text] [Related]
7. Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening.
Cappella P; Giorgini ML; Ernestina Re C; Ubezio P; Ciomei M; Moll J
Cytometry A; 2010 Oct; 77(10):953-61. PubMed ID: 21290469
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric bromodeoxyuridine (BrdU)/DNA analysis using fresh solid tumors and its clinical significance].
Shimabukuro T; Naito K
Nihon Rinsho; 1992 Oct; 50(10):2391-4. PubMed ID: 1447808
[TBL] [Abstract][Full Text] [Related]
9. [An experimental study of anticancer agent sensitivity test in human gastric cancer cell lines by flow cytometry].
Katayanagi N
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):827-36. PubMed ID: 2118987
[TBL] [Abstract][Full Text] [Related]
10. Cell kinetic changes in cultured tumor cells after treatment with radiation and chemotherapy.
Murata T; Akagi K; Uda M; Kimura H; Nasu R; Tanaka Y
Int J Oncol; 1998 Jan; 12(1):171-4. PubMed ID: 9454901
[TBL] [Abstract][Full Text] [Related]
11. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G
J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050
[TBL] [Abstract][Full Text] [Related]
12. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
[TBL] [Abstract][Full Text] [Related]
13. [Estimation of cell viability by FCM using rhodamin 123 and propidum iodide--its application in evaluating the effect of anticancer drugs to tumor cells].
Sasaki K; Tanaka K; Murakami T; Ogino T; Kawasaki M; Takahashi M; Tenjin T
Gan No Rinsho; 1988 Jan; 34(1):13-6. PubMed ID: 2448503
[TBL] [Abstract][Full Text] [Related]
14. [Cell kinetic effect of carcinostatic agents using BrdU and its monoclonal antibody].
Tsuji Y; Hashimoto K; Takeda J; Kakegawa T
Nihon Rinsho; 1992 Oct; 50(10):2381-5. PubMed ID: 1333016
[TBL] [Abstract][Full Text] [Related]
15. Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin).
Kawamoto K; Wada Y; Kumazawa H; Yamashita T; Kumazawa T; Matsumura H
Cytometry; 1992; 13(3):307-13. PubMed ID: 1374308
[TBL] [Abstract][Full Text] [Related]
16. [Chemo-sensitivity test for malignant brain tumors by DNA histogram, in vitro].
Nomura K; Nagane M; Shibui S
Nihon Rinsho; 1992 Oct; 50(10):2374-80. PubMed ID: 1447807
[TBL] [Abstract][Full Text] [Related]
17. [Study of flow cytometric BrdU/DNA assay].
Shimabukuro T; Yamamoto M; Mitsui H; Yamamoto N; Sakatoku J; Shinohara Y
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1249-55. PubMed ID: 2794649
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric evaluation of apoptosis and cell viability as a criterion of anti-tumour drug toxicity.
Michie J; Akudugu J; Binder A; Van Rensburg CE; Böhm L
Anticancer Res; 2003; 23(3B):2675-9. PubMed ID: 12894557
[TBL] [Abstract][Full Text] [Related]
19. Different effects of two cyclic chalcone analogues on cell cycle of Jurkat T cells.
Rozmer Z; Berki T; Perjési P
Toxicol In Vitro; 2006 Dec; 20(8):1354-62. PubMed ID: 16828254
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric bromodeoxyuridine (BrdU)/DNA analysis--study with urogenital tumors].
Shimabukuro T; Yoshihiro S; Matsuyama H; Yamamoto N; Sakatoku J
Hinyokika Kiyo; 1989 Oct; 35(10):1653-7. PubMed ID: 2610171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
